Ruta graveolens Garden rue, Herby grass   Family: Rutaceae
Goat's rue is Galega officinalis.
PART  USED: Aerial parts.
TASTE: Pungent   ODOR: Strong and characteristic.
ACTIONS
1. Spasmolytic.[1] Antispasmodic.[2]
2. Emmenagogue.[1,2] Usually used as a uterine stimulant.[2]
3. Antitussive.[1]
4. Stimulant.[2]
INDICATIONS
1. Amenorrhea- atonic.[1]
CONTRAINDICATIONS: Pregnant women.[2]
COMBINATIONS
- Suppressed menses, use with False unicorn root and Life root plant.
PREPARATIONS:    3X /day
Powdered herb  0.5-1g or by infusion.[1] 1-2 g.[2]
Liquid extract  1:1 in 25% alcohol  0.5-1 ml.[1] 2-4 ml.[2]

ORIGIN: Southern Europe, cultivated in Britain.
HABITAT: Wild or cultivated, in apen sunny position.
DESCRIPTION
References
Inner Path can not take any responsibility for any adverse effects from the use of plants. Always seek advice from a professional before using a plant medicinally.

Constituents

Research
The essential oil is anthelmintic. The furocoumarins can cause phototoxicity; this property is utilized in the treatment of psoriasis by psoralen derivatives.[1,2]
Rutin hasbeen investigated for its ability to reduce capillary fragility and is often taken as food supplement- the "Vitamin P". Its other propertes include anti-edema effects,[3] and it may be responsible for the antiinflammatory effect of the herb observed in animal tests.[4] It has also been shown to inhibit tumour formation on mouse skin induced by benzo(a)pyrene.[5] Also increase survival times of rats fed a thrombogenic diet.[6]
References
[1] Martindale. The Extra Pharmacopoeia, 27th Ed. Pub. The Pharmaceutical Press (1977) UK
[2] Opdyke, D.L.J. (1975) Food Cosmet. Toxicol. 13, Suppl.713
[3] Encyclopedia of Common Natural Ingredients used in Food Drugs and Cosmetics, Albert Y. Leung. Pub. John Wiley & Sons Inc. (1980) NY
[4] Mascolo, N. et al. (1987) Phytother. Res. 1 (1), 28
[5] Van Duuren, B.L. et al. (1971) J. Natl. Cancer Inst. 46, 1039
[6] Robbins, R.C. (1967) J. Atheroscer. Res. 7,3

Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.
Fadlalla K, Watson A, Yehualaeshet T, Turner T, Samuel T.
Abstract
BACKGROUND:
Ruta graveolens is a medicinal herb that has been used for centuries against various ailments. This study examined the anticancer properties of the herb using cancer cell lines.
MATERIALS AND METHODS:
Methanolic extract of R. graveolens was tested on colon, breast and prostate cancer cells. Viability, cell cycle profiles, clonogenicity and capase activation were measured. Induction and subcellular localizations of p53, 53BP1 and ?-H2AX proteins were examined.
RESULTS:
The extract dose-dependently decreased the viability and the clonogenicity of treated cells and induced G2/M arrest, aberrant mitoses, and caspase-3 activation. It also induced the p53 pathway and focal concentration of the DNA damage response proteins 53BP1 and ?-H2AX. Moreover, the levels of phospho-Akt and cyclin B1 were reduced by treatment, whereas only cyclin B1 was reduced in normal dermal fibroblasts.
CONCLUSION:
R. graveolens extract contains bioactive compounds which, independently of known photoactivatable mechanisms, potently inhibit cancer cell proliferation and survival through multiple targets.
PMID: 21273604 PMCID: PMC3124362  Anticancer Res. 2011 Jan;31(1):233-41. ncbi.nlm.nih.gov

Anti-tumour activity of Ruta graveolens extract.
Preethi KC, Kuttan G, Kuttan R.
Abstract
An extract of Ruta graveolens was found to be cytotoxic to Dalton's lymphoma ascites (DLA), Ehrlich ascites carcinoma (EAC) and L929 cells in culture (IC100=16 mg/ml) and also to increase the lifespan of tumour bearing animals. The extract further decreased solid tumours developing from DLA and EAC cells when given simultaneously with elongation of the lifespan of tumour-bearing animals. A homeopathic preparation of Ruta graveolens (200 c) was equally effective. Neither was effective for reducing already developed tumours. The Ruta graveolens extract was found to scavenge hydroxyl radicals and inhibit lipid peroxidation at low concentrations. However, at higher concentrations the extract acted as a prooxidant as inhibition of lipid peroxidation and scavenging of hydroxyl radical was minimal. These data indicates that the prooxidant activity of Ruta graveolens may be responsible for the cytocidal action of the extract and its ability to produce tumour reduction.
PMID: 17059340  Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):439-43. ncbi.nlm.nih.gov

Garden rue inhibits the arachidonic acid pathway, scavenges free radicals, and elevates FRAP: role in inflammation
Manjir Sarma Kataki, Bibhuti B Kakoti, Biman Bhuyan, Ananya Rajkumari, Prakash Rajak
Abstract
Aim: In the present study, the anti-inflammatory and antioxidant activities of the methanol extract of Ruta graveolens leaves (RG-M) were evaluated using various in vivo and in vitro models.
Method: For anti-inflammatory activity, RG-M was administered by the oral route (p.o.) in a carrageenan-induced paw edema model, and by the intraperitoneal route (i.p.) in an exudative inflammation model. In vitro inhibition of cyclooxygenase and lipoxygenase enzymes was evaluated. In vitro antioxidant activity was also examined. Endogenous antioxidant status was further evaluated by ferric reducing ability of plasma model.
Results: RG-M showed maximum inhibition of carrageenan-induced edema (100 mg·kg-¹ - 33.36%; 200 mg·kg-¹ - 45.32% and 400 mg·kg-¹ - 56.28%). In the exudative inflammation model, a significant reduction in leukocyte migration (200 mg·kg-¹ - 54.75% and 400 mg·kg-¹ - 77.97%) and protein exudation (200 mg·kg-¹ - 31.14% and 400 mg·kg-¹ - 49.91%) were observed. RG-M also exhibited inhibition of COX-1 (IC50 182.27 µg·mL-¹) and COX-2 (IC50 190.16 µg·mL-¹) as well as 5-LOX (IC50 215.71 µg·mL-¹). Antioxidant activity was significant with improved endogenous antioxidant status.
Conclusion: The results demonstrated the anti-inflammatory and antioxidant activity of RG-M with potent inhibitory effects on the arachidonic acid pathways.
Chin J Nat Med 2014 Mar;12(3):172-9. doi: 10.1016/S1875-5364(14)60029-7. PMID: 24702802 DOI: 10.1016/S1875-5364(14)60029-7 pubmed.ncbi.nlm.nih.gov